Straits Research Pvt Ltd
Defibrillator Market Size is projected to reach USD 21 Billion by 2030, growing at a CAGR of 7.18%: Straits Research
03 août 2022 13h00 HE | Straits Research
New York, United States, Aug. 03, 2022 (GLOBE NEWSWIRE) -- A Defibrillator administers a therapeutic shock to a patient's heart in life-threatening circumstances such ventricular fibrillation,...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Physician-Initiated Research Protocol at The Kansas City Heart Rhythm Institute
21 juil. 2022 10h00 HE | BioSig Technologies, Inc.
Westport, CT, July 21, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Purchase Agreement with Kansas City Heart Rhythm Institute at Overland Park Regional Medical Center
07 juil. 2022 08h30 HE | BioSig Technologies, Inc.
Westport, CT, July 07, 2022 (GLOBE NEWSWIRE) -- OPRMC marks our first leasing agreement under new program Company also inks national master agreement with one of the largest U.S. healthcare...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Closing of Public Offering of Common Stock
29 juin 2022 17h45 HE | BioSig Technologies, Inc.
Westport, CT, June 29, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Pricing of Public Offering of Common Stock
24 juin 2022 09h30 HE | BioSig Technologies, Inc.
Westport, CT, June 24, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
Bio-Sig-Logo-horiz.jpg
BioSig Announces Proposed Public Offering of Common Stock
23 juin 2022 16h26 HE | BioSig Technologies, Inc.
Westport, CT, June 23, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (Nasdaq: BSGM) (“BioSig” or the “Company”), a medical technology company commercializing an innovative biomedical signal...
Bio-Sig-Logo-horiz.jpg
BioSig Announces New Evaluation Agreement for its PURE EP System with Cleveland Clinic
22 juin 2022 08h00 HE | BioSig Technologies, Inc.
Westport, CT, June 22, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”) a medical technology company advancing electrophysiology workflow by delivering...
researchdrivelogo.jpg
Organ Care System Market for Heart Expected to Accumulate a Revenue of $37.2 Million by 2026, Growing at a Healthy CAGR of 16.5% | Reveals [90-Pages] by Research Dive
08 juin 2022 09h00 HE | Research Dive
New York, USA, June 08, 2022 (GLOBE NEWSWIRE) -- According to the latest report published by Research Dive, the global organ care system market for heart is anticipated to rise at a stable CAGR of...
Bio-Sig-Logo-horiz.jpg
BioSig Advances its PURE™ System Commercial Launch to Medical Centers Nationwide
26 mai 2022 09h08 HE | BioSig Technologies, Inc.
Westport, CT, May 26, 2022 (GLOBE NEWSWIRE) -- Commercial pipeline to include 30 advanced leads at Medical Centers of Excellence Company’s development and operational infrastructure...
Bio-Sig-Logo-horiz.jpg
BioSig’s PURE EP™ System to be Featured During EPLive 2022
25 mai 2022 09h47 HE | BioSig Technologies, Inc.
Westport, CT, May 25, 2022 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM) (“BioSig” or the “Company”), a medical technology company advancing electrophysiology workflow by delivering...